Logo 1 Logo 2

Clinical Trial Details

Trial ID: L1541
Source ID: NCT00224081
Associated Drug: Sodium Ferric Gluconate,
Title: DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Acronym: DRIVE
Status: COMPLETED
Study Results: NO
Results:
Conditions: Anemia, Iron-Deficiency|Kidney Failure, Chronic|Hemodialysis
Interventions: DRUG: Sodium ferric gluconate,
Outcome Measures: Primary: Change in hemoglobin and anemia medications, 6 weeks | Secondary: Change in various iron indices, 6 weeks
Sponsor/Collaborators: Sponsor: Watson Pharmaceuticals
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 134
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2004-09
Completion Date:
Results First Posted:
Last Update Posted: 2015-12-10
Locations: Bakersfield, California, United States|Glendale, California, United States|Los Angeles, California, United States|Santa Rosa, California, United States|Torrance, California, United States|Lauderdale Lakes, Florida, United States|Tampa, Florida, United States|Roswell, Georgia, United States|Waycross, Georgia, United States|Crestwood, Illinois, United States|Wichita, Kansas, United States|Shreveport, Louisiana, United States|Boston, Massachusetts, United States|Kalamazoo, Michigan, United States|Royal Oak, Michigan, United States|Columbia, Missouri, United States|St Louis, Missouri, United States|North Brunswick, New Jersey, United States|Brooklyn, New York, United States|Minneola, New York, United States|New York, New York, United States|Youngstown, Ohio, United States|Philadelphia, Pennsylvania, United States|Chattanooga, Tennessee, United States|Knoxville, Tennessee, United States|Arlington, Texas, United States|Houston, Texas, United States|San Antonio, Texas, United States|Morgantown, West Virginia, United States
URL: https://clinicaltrials.gov/show/NCT00224081

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress